Implications of the innate immune response to adenovirus and adenoviral vectors

Area of Science:

• Immunology
• Virology
• Gene Therapy

Background:

• Adenovirus (AdV) is a common pathogen causing respiratory illnesses in diverse populations.
• While generally mild in healthy individuals, AdV infection can be severe in immunocompromised patients or in crowded conditions.
• Adenovirus vectors were initially promising for gene therapy but face challenges due to immune system reactions.

Purpose of the Study:

• To examine the innate immune response to wild-type Adenovirus (AdV) infection.
• To investigate the immune response to AdV-based gene therapy vectors.
• To emphasize the pulmonary inflammatory response to AdV and its implications for vector development.

Main Methods:

• Review of existing literature on Adenovirus immunology and gene therapy.
• Focus on studies detailing the innate immune mechanisms activated by AdV.
• Analysis of research on AdV vector-induced toxicity and transgene expression limitations.

Main Results:

• Innate and adaptive immune responses to AdV vectors lead to increased toxicity.
• Immune reactions limit the duration of transgene expression from AdV vectors.
• The pulmonary inflammatory response is a key factor in AdV vector efficacy and safety.

Conclusions:

• Understanding the innate immune response to AdV is crucial for improving gene therapy vectors.
• Newer vector designs aim to mitigate adverse immune reactions.
• Targeting AdV-induced inflammation may enhance the safety and effectiveness of gene therapy.